uniQure Inc : uniQure to Participate in Multiple Upcoming Industry Conferences in April finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Amgen To Present At Guggenheim Healthcare Talks Oncology Day
Amgen today announced that Greg Friberg vice president and global oncology therapeutic area head at Amgen, will participate in a fireside chat as part of the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, Feb. 12 at 12:30 p.m. ET . Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The …
– Amgen (NASDAQ:AMGN) today announced that Greg Friberg vice president and global oncology therapeutic area head at Amgen, will participate in a fireside chat as part of the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, Feb. 12 at 12:30 p.m. ET .
Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day
NEW HAVEN, Conn., Feb. 08, 2021 (GLOBE NEWSWIRE) Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President and Chief Executive Officer and Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks: 2021 Oncology Day on Thursday, February 11 at 4:30 p.m. ET.
A live audio webcast of the presentation will be available here and on Arvinas’ website at www.arvinas.com. A replay of the webcast will be archived on Arvinas’ website for 30 days following the presentation.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
CRISPR Therapeutics AGFebruary 5, 2021 GMT
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 05, 2021 (GLOBE NEWSWIRE) CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, February 12, 2021, at 3:30 p.m. ET.
A live webcast of the event will be available on the “Events & Presentations” page in the Investors section of the Company’s website at https://crisprtx.gcs-web.com/events. A replay of the webcast will be archived on the Company’s website for 14 days following the presentation.
Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 4, 2021 /PRNewswire/ Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced they will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Days on Thursday, February 11
th at 9:00 a.m. ET/6:00 a.m. PT. Dan Faga, Executive Vice President and Chief Operating Officer, will represent Mirati at the event.
The webcast will be available through the Investors section of the Mirati website at https://ir.mirati.com/events-and-presentations/default.aspx, and a replay of the webcast will be made available for 90 days following the event.